Michael H B Stowell

Title: Michael H B Stowell: Innovator in Drug Targeting Technologies

Introduction

Michael H B Stowell is a notable inventor based in Pasadena, CA (US). He has made significant contributions to the field of drug delivery and targeting technologies. With a total of 3 patents, his work focuses on enhancing the efficacy of drug administration, particularly in neurological applications.

Latest Patents

Stowell's latest patents include innovative methods for drug targeting. One of his key inventions is the development of covalent polar lipid conjugates with neurologically active compounds. This invention describes a method for facilitating the entry of drugs into cells and tissues at physiologically protected sites. It also provides a means for targeting drugs to specific organelles within the cell. This technology is particularly beneficial for psychotropic, neurotropic, and neurological drugs, allowing for rapid and efficient introduction across the blood-brain barrier.

Another significant patent involves a conjugate of biologically active compounds and polar lipids linked to microparticles for biological targeting. This method allows for the specific targeting of antiviral and antimicrobial drugs to particular sites within phagocytic mammalian cells. The invention enhances the effectiveness of prodrugs by linking them to polar lipids, ensuring activation within infected cells.

Career Highlights

Throughout his career, Stowell has worked with prestigious institutions such as Oregon Health & Science University and the California Institute of Technology. His research has focused on advancing drug delivery systems, particularly for challenging neurological conditions.

Collaborations

Stowell has collaborated with notable professionals in his field, including Milton Yatvin and Michael J Meredith. These collaborations have contributed to the development of innovative solutions in drug targeting and delivery.

Conclusion

Michael H B Stowell's contributions to drug targeting technologies have the potential to revolutionize the treatment of neurological disorders. His innovative patents reflect a commitment to improving drug efficacy and patient outcomes.